{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:57:22Z","timestamp":1791482242250,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.atherosclerosis.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T11:52:48Z","timestamp":1623325968000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["LDLR variants functional characterization: Contribution to variant classification"],"prefix":"10.1016","volume":"329","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-7542","authenticated-orcid":false,"given":"Ana Catarina","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"Benito-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Gra\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unai","family":"Galicia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Bourbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"80-","key":"10.1016\/j.atherosclerosis.2021.06.001_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib2","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial hypercholesterolemia--epidemiology, diagnosis, and screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autossomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib5","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1073\/pnas.84.19.6919","article-title":"Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding","volume":"84","author":"Innerarity","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/humu.23634","article-title":"ClinGen FH variant curation expert panel, ClinVar database of global familial hypercholesterolemia-associated DNA variants","volume":"39","author":"Iacocca","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","volume":"20","author":"Chora","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/gim.2015.14","article-title":"The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia","volume":"17","author":"Benito-Vicente","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jmg.2007.057000","article-title":"Genetic diagnosis of familial hypercholesterolaemia: the importance of functional analysis of potential splice-site mutations","volume":"46","author":"Bourbon","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib11","first-page":"1","article-title":"Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement","volume":"18","author":"Medeiros","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.atherosclerosis.2010.07.012","article-title":"Update of the Portuguese familial hypercholesterolaemia study","volume":"212","author":"Medeiros","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2012.08.017","article-title":"In vitro functional characterization of missense mutations in the LDLR gene","volume":"225","author":"Silva","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/humu.21630","article-title":"Functional characterization of splicing and ligand-binding domain variants in the LDL receptor","volume":"33","author":"Etxebarria","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/humu.20256","article-title":"Update of the molecular basis of familial hypercholesterolemia in The Netherlands","volume":"26","author":"Fouchier","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/humu.9264","article-title":"Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR","volume":"24","author":"Mozas","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib18","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.ATV.17.11.3092","article-title":"Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group","volume":"17","author":"Sun","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jmg.35.7.573","article-title":"Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland","volume":"35","author":"Lee","year":"1998","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1098-1004(1998)11:5<413::AID-HUMU17>3.0.CO;2-F","article-title":"Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia. Mutations in brief no. 135. Online","volume":"11","author":"Cenarro","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib21","article-title":"Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor","volume":"57","author":"Koivisto","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Ivan","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib25","first-page":"999","article-title":"Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results","volume":"25","author":"Bourbon","year":"2006","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/gim.2015.71","article-title":"Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement","volume":"18","author":"Medeiros","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.atherosclerosis.2007.07.019","article-title":"Familial hypercholesterolaemia in Portugal","volume":"196","author":"Bourbon","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2017.04.002","article-title":"Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: the SAFEHEART registry","volume":"262","author":"Bourbon","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/(SICI)1097-0320(19971015)30:5<264::AID-CYTO7>3.0.CO;2-H","article-title":"Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia","volume":"30","author":"Urdal","year":"1997","journal-title":"Cytometry"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.atherosclerosis.2016.08.037","article-title":"Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia","volume":"253","author":"Grenkowitz","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib31","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112677","article-title":"Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment","volume":"9","author":"Etxebarria","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004855","article-title":"Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction","volume":"11","author":"Thormaehlen","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2016.04.022","article-title":"Functional analysis of the p.(Leu15Pro) and p.(Gly20Arg) sequence changes in the signal sequence of LDL receptor","volume":"250","author":"Pavlou\u0161kov\u00e1","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.06.001_bib35","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41598-020-58734-9","article-title":"Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR","volume":"10","author":"Galicia-Garcia","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021002720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021002720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:46:03Z","timestamp":1758156363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021002720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"alternative-id":["S0021915021002720"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.06.001","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDLR variants functional characterization: Contribution to variant classification","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}